91591-19-4

Upstream product

• 2733-41-7 4-nitrobenzoyl azide 
• 78499-66-8 C₂₇H₂₁BO₈ 
• 91593-27-0 (7S,9S)-7,8,9,10-tetrahydro-6,7,9,11-tetrahydroxy-9-<<<(4-nitrophenyl)carbamoyl>oxy>methyl>-5,12-naphthacenedione 
• 91593-28-1 4-Nitro-benzoic acid (2S,3S,4S,6R)-2-methyl-4-(2,2,2-trifluoro-acetylamino)-6-[(1S,3S)-3,5,12-trihydroxy-3-(4-nitro-phenylcarbamoyloxymethyl)-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy]-tetrahydro-pyran-3-yl ester 
• 91593-29-2 (4-Nitro-phenyl)-carbamic acid (2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-2-yloxy]-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-2-ylmethyl ester 

Relevant academic research and scientific papers

Synthesis and antitumor activity of 9-[(carbamoyloxy)alkyl]anthracyclines: A novel class of anthracycline derivatives

a number of 4-demethoxyanthracyclines having hydroxylalkyl functions at the 9-position have previously been synthesized and shown to have potent antitumor activity. A series of carbamate derivatives of these (hydroxyalkyl)anthracyclines have now been prep

Anthracycline glycosides

This invention relates to compounds of the formula STR1 wherein R is a hydrogen atom, a lower alkyl, aryl or aryl-(lower alkyl) group, a 5-membered or 6-membered heteroaromatic group in which the hetero atom is nitrogen, oxygen or sulphur or a group of th